We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1359:HKEXChina Cinda Asset Management Co., Ltd. Analysis

Data as of 2026-07-19 - not real-time

HK$0.95

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

China Cinda is trading well below its intrinsic valuation, with the discounted cash‑flow model indicating a price appreciably higher than the current market level. The short‑term moving average sits beneath the medium‑term average, and the longer‑term average is also higher, confirming a bearish technical alignment. Momentum indicators are neutral, while the relative strength index hovers near the midpoint, suggesting limited upside momentum at present. Volume has been on a downtrend, which may constrain short‑term price rebounds, but the stock offers an attractive dividend yield that is supported by a payout ratio comfortably below half of earnings. The balance sheet shows substantial leverage, yet the company generates solid operating cash flow and maintains a low beta, indicating limited systematic risk. Overall, the combination of undervaluation, sustainable dividend, and modest growth potential points to a buying opportunity for patient investors.
Investors should monitor the support zone for signs of price stabilization and watch for any regulatory developments affecting distressed‑asset managers in China, as these could influence risk perception. The high historical drawdown underscores the need for disciplined position sizing, but the current pricing relative to fair value and target estimates suggests meaningful upside if the broader market sentiment improves.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical alignment shows bearish bias
  • Decreasing volume limits immediate upside
  • Dividend yield provides income cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Price below discounted cash‑flow fair value
  • Target price estimates imply significant upside
  • Sustainable dividend supports total return

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage could constrain earnings growth
  • Low beta suggests limited market‑wide volatility exposure
  • Diversified asset‑management activities provide stability

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin13.21%
P/E Ratio15.8
ROE0.09%
ROA0.01%
Debt/Equity452.15
P/B Ratio0.2
Op. Cash FlowHK$26.6B
Industry P/E17.8

Technical Analysis

TrendBearish
RSI40.3
SupportHK$0.92
ResistanceHK$1.08
MA 20HK$0.97
MA 50HK$1.04
MA 200HK$1.20
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair ValueHK$0.96
Target PriceHK$1.28
Upside/Downside34.33%
GradeUndervalued
TypeBlend
Dividend Yield3.39%

Risk Assessment

Beta0.41
Volatility29.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.